AHA ACLS Flashcards

1
Q

Cardiac Arrest

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pVT/VF) Repeated dos

A

Immediate Defib (initial 200J), CPR, Antiarrhythmic & EPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stable vs Medical PT assessment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NCT stable vs unstable

A

Stable} Vagal, medicate, SVT (Adeno & Diltiazem) other NCT (Diltiazem, Verapamil, Beta-Blockers)
Unstable} Cardiovert SVT 50-100 (AFib RVR 120-200)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WCT stable vs unstable

A

Stable} Med (Procain
Unstable} usually cardiovert 100-200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ROSC

A

Dopamine, Infusion if needed, TCP probably

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adult Bradycardia

A

Unstable) TCP
Stable) Medicate (atropine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bradycardia stable vs unstable

A

Stable} medicate (Atropine)
Unstable} TCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardiovert dose

A

Inital 100J
200, 300, 360J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TCP) doing

A
  1. Turn Pacer on
  2. 80BPM
  3. mA sync till capture
  4. check mechanical
  5. Increase 2-5mA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Defib) Biphasic end max dose
Monophasic end max dose

A

= 120-200j
= 360j

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CPR) simple cycle

A
  1. Rhythm pulse check
  2. Defib if needed
  3. CPR 30:2
  4. Medicate appropriately
  5. RHYTHM/PULSE CHECK
  6. SHOCK IF NEEDED IF NOT CPR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cardioversion/vert) Indication
Rhythms
intial & after Doses:

A

= UNSTABLE} SBP <90 & AMS
= Bradycardia, AF w/ SVR,
= 50-100J then 200J 300J 360J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Defib) indication
Contra:
Rhythms
Initial & after doses:

A

= “Dead fibers” TdP (only rhythm defib awake)
= Asystole VT w/ Pulse stable
= pVT, VF, TdP
= 100J 200J 300J 360J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pacing) indication
Rhythms
Initial & after:

A

= “pick up the pace” <50BPM UNSTSBLE} SBP <90 & AMS
= BPM <50
= 80BPM mA till’ capture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Monophasic monitor Jules max
Biphasic monitor Jules max

A

360J
200J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Bradycardia Stable vs Unstable

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Asystole & PEA 3 needs

A

CPR, NEVER SHOCK, EPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

ROSC

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

CPR tasks/delegating

A

2 people) 30:2, Airway, IO access, self scribe & timer
4-5 people) Pit crew, 2 rotating CPR, 1 BVM, partner checking pulse sites, Medicate, Self shock & admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

SVT treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Bradycardia treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

AFib w/ RVR treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

VT treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

pVT/VF treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

TCP
Defib
Cardiovert

A

= “pick up the pace” unstable bradycardias
= “for dead fibbers” pVT, VF, TdP
= “Convert to regular speed” Unstable Tachycardias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Defib initial dose:
Cardiovert initial dose:
TCP initial dose:

A

= 100-200
= 50-100 (120-200 AF RVR)
= 80BPM, mA till capture ~50 to 85mA (start 50mA like BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Procainamide)class:
Dynamics:

A

= 1a antiarrhythmic
= Blocks Na channels in cardiac cells which causes depolarization to slow & decrease automaticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Procainamide) indications:

Contra:

A

=V-Tach w/ pulse, Pre-excitation rhythms (WPW)
=Shouldn’t admin to PTs received IV Ca channel blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Procainamide)effect:

4 ending points:

A

= Drowsy, Slurred speech, Confusion, Seizures, HypoBP
1. Termination of rhythm
2. HypoBP
3. Widening QRS>50%
4. Meet the max total dose (17mg/kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Procainamide) max dose:
Recurrent VF/VT:
Urgent situations:
Maintenance Infusion:

A

= (max total dose: 17mg/kg)
= 20mg/min (max total dose: 17mg/kg)
= up to 50mg/min may admin/ to total dose (max 17mg/kg)
= 1-4mg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Verapamil) class:
pharmacodynamics:

A

= IV antiarrhythmic Ca channel blocker
= Slows AP of autorhythmic cells in heart by blocking Ca channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Cardioversion/vert) Indication
Rhythms
intial & after Doses:

A

= UNSTABLE} SBP <90 & AMS
= Bradycardia, AF w/ SVR,
= 50-100J then 200J 300J 360J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Defib) indication
Contra:
Rhythms
Initial & after doses:

A

= “Dead fibers” TdP (only rhythm defib awake)
= Asystole VT w/ Pulse stable
= pVT, VF, TdP
= 100J 200J 300J 360J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Pacing) indication
Rhythms
Initial & after:

A

= “pick up the pace” <50BPM UNSTSBLE} SBP <90 & AMS
= BPM <50
= 80BPM mA till’ capture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Monophasic monitor Jules max
Biphasic monitor Jules max

A

360J
200J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Procainamide)class:
Dynamics:

A

= 1a antiarrhythmic
= Blocks Na channels in cardiac cells which causes depolarization to slow & decrease automaticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Procainamide) indications:

Contra:

A

=V-Tach w/ pulse, Pre-excitation rhythms (WPW)
=Shouldn’t admin to PTs received IV Ca channel blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Procainamide)effect:

4 ending points:

A

= Drowsy, Slurred speech, Confusion, Seizures, HypoBP
1. Termination of rhythm
2. HypoBP
3. Widening QRS>50%
4. Meet the max total dose (17mg/kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Procainamide) max dose:
Recurrent VF/VT:
Urgent situations:
Maintenance Infusion:

A

= (max total dose: 17mg/kg)
= 20mg/min (max total dose: 17mg/kg)
= up to 50mg/min may admin/ to total dose (max 17mg/kg)
= 1-4mg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Verapamil) class:
pharmacodynamics:

A

= IV antiarrhythmic Ca channel blocker
= Slows AP of autorhythmic cells in heart by blocking Ca channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

L)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

L)

A
56
Q

L)

A
57
Q

L)

A
58
Q

L)

A
59
Q

L)

A
60
Q

Propranolol, Labetalol, Metoprolol) class
Labetalol
Metoprolol

A

= class 2 Beta Blockers
= 2nd line med for SVT after Adenosine, A-fib/flutter w/RVR, Reduce myocardical ischemia in AMI PT’s w/elevated HR, Antihypertensive
= Hypertension, 2nd line med for A-Fib/A-Flutter w/ RVR, & SVT

61
Q

Procainamide & Lidocaine) class

A

= class 1A&B Na Channel Blockers
= Alterative to Amiodarone in cardiac arrest V-Fib/pVT, Stable monomorphic Ventricular TachyC w/ presserved LVF
= V-Tach with a pulse, pre-excitation rhythms (WPW) >50% QRS width

62
Q

Amiodarone class & indication

A

Class 3 K channel blocker> VF/Pulseless VT unresponsive to shock, CPR & Epi, BradyCs to include AV blocks, Recurrent, hemodynamically unstable VT w/ pulse

63
Q

Procainamide & Lidocaine) class

A

= class 1A&B Na Channel Blockers
= Alterative to Amiodarone in cardiac arrest V-Fib/pVT, Stable monomorphic Ventricular TachyC w/ presserved LVF
= V-Tach with a pulse, pre-excitation rhythms (WPW) >50% QRS width

64
Q

Diltiazem & Verapamil) class
Diltiazem
Verapamil

A

= class 4 Ca channel blocker
= 1st line med for A-Fib/Flutter w/ RVR >150 bpm, 2nd line med for SVT
refractory to adenosine
= 2nd line med for A-Fib/Flutter w/ RVR. May use as alterative after adenosine, narrow QRS complex tachycardia w/ preserved LV fn.

65
Q

Cardioversion/vert) Indication
Rhythms
intial & after Doses:

A

= UNSTABLE} SBP <90 & AMS
= Bradycardia, AF w/ SVR,
= 50-100J then 200J 300J 360J

66
Q

Defib) indication
Contra:
Rhythms
Initial & after doses:

A

= “Dead fibers” TdP (only rhythm defib awake)
= Asystole VT w/ Pulse stable
= pVT, VF, TdP
= 100J 200J 300J 360J

67
Q

Pacing) indication
Rhythms
Initial & after:

A

= “pick up the pace” <50BPM UNSTSBLE} SBP <90 & AMS
= BPM <50
= 80BPM mA till’ capture

68
Q

Monophasic monitor Jules max
Biphasic monitor Jules max

A

360J
200J

69
Q

Antiarrhythmics for pVT, TdP, VF

A

pVT/ TdP= Lidocaine & Aminodarone
Tdp= Mag-Sulfate

70
Q

SVT shock dose

A

Cardiovert 50-100/200/300/360J

71
Q

AFib w/ RVR shock dose

A

Cardiovert 120-200/300/360J

72
Q

A-Flutter w/ RVR shock dose

A

Cardiovert 50-100/200/300/360J

73
Q

VT with pulse &unstable shock dose
pVT & VF shock

A

cardiovert 100/200/300/360J
Defib 200J 300/360J

74
Q

Tdp shock dose

A

defib 200/300/360J

75
Q

SVT stable RX

A

Vagal, Adenosine 6mg 12mg, Diltiazem 0.25mg/kg (M20mg) 0.35/kg (M25mg)

76
Q

AFib & Flutter w/ RVR, MAT, Junctional tachycardia stable RX:

A

= DONT VAGAL, Diltiazem 0.25mg/kg (M20mg) 0.35/kg (M25mg), Verapamil 2.5-5mg, Beta-Blockers

77
Q

Bradycardia Stable Rx

A

Atropine 1mg/3-5mins

78
Q

Diazepam/Versed) Adult Dose:

A

2.5-10 mg in 2.5 mg increments slow IV/IO/IM

79
Q

Aspirin)

A

=160-325mg PO

80
Q

Atropine) Bradycardia (w/ or w/o ACS) dose:
Severe dose:
Organophosphate poisoning:

A

=1 mg IVP 3-5mins as needed (Don’t exceed 0.04mg/Kg (total 3mg))
=1mg IVP (3mins) in severe clinical conditions
=2-4mg (or higher) IVP

81
Q

Epinephrine 1:10,000): Cardiac arrest:
Bradycardia dose:
Normovolemic hypotension & severe anaphylaxis:

A

=1mg IVP/IOP every 3-5mins
=2-10mcg/min IV/IO infusion (0.002-
=2-10mcg per min—> mix 1mg of Epi 1:10,000 into a 1 liter bag of fluid

82
Q

Fentanyl):
IN route:

A

=1mcg/kg to max of 100mcg (IV/IO/IN) → may repeat PRN in 5-10mins
=Max of 1mL per nare admin/ed IN

83
Q

Labetalol):

A

10mg IV/IO push over 1-2mins & May repeat every 10mins to a max dose of 150mg

84
Q

Mag-Sulfate)Cardiac arrest due to suspected hypomagnesemia/ Tdp:
Tdp w/ pulse:
Maintenance infusion:

A

= 1-2grams diluted in 10mL
= 1-2grams mixed in 50-100mL admin/ over 5-60mins
=0.5-1gram per hour

85
Q

Morphine): STEMI:
NSTEMI-ACS:

A

= 2-4mg IV/IO (slow); may give + doses of 2-8mg IV at 5-15min intervals
=0.1mg/kg IV/IO (slow) or IM up to 10mg

86
Q

Nitroglycerin):

A

= 0.4mg SL (pill or spray) → repeat 3x (Q5 mins) for total dose of 1.2mg

87
Q

NORepinephrine):

A

= 0.1-0.5mcg/kg/min IV/IO infusion

88
Q

Ondansetron (Zophran):

A

= 4-8mg IV (slow), IM, PO

89
Q

Procainamide): Recurrent VF/VT:
Maintenance Infusion:
Urgent situationships:

A

= 20mg/min (max total dose: 17mg/kg)
= 1-4mg/min
= up to 50mg/min may be admin/ to total dose of 17mg/kg

90
Q

Verapamil): 1st:
2nd:
Max dose:

A

=2.5-5mg IV/IO bolus over 2-3mins
= 5-10mg over 2-3 mins
=20mg

91
Q

Etomidate (Amidate) IVP:

A

= 0.2-0.4 mg/kg (limit to 1 dose) Onset w/in 30 secs. Duration: 5-10 mins

92
Q

Ketamine (Ketalar): IVP:

A

= 1-2mg/kg, Onset 1 min, Durations 10-20 mins

93
Q

Diltiazem) 1st dose:
2nd dose:

A

= 0.25 mg/kg (max dose 20 mg)
= 0.35 mg/kg (max dose 25 mg)

94
Q

Dopamine) Dosing:
Adult & Pedi Cardiac dose:
Adult & Pedi Vasopressor dose:

A

= 2–20 mcg/kg/min Titrate to patients response
= 5-10mcg/kg/min
= 10-20 mcg/kg/min

95
Q

Epi 1:10,000) Admin via:
(Adult) Cardiac Arrest dose:
(Adult) Bradycardia dose:
(PEDI) Bradycardia/Cardiac Arrest dose:
(PEDI) Hypoperfusion & Severe anaphylaxis dose:

A

= IV infusion drip
= 1mg IVP/IOP every 3-5 mins
= 2-10 mcg/min IV/IO infusion
= 0.01 mg/kg or 0.1 mL/kg
= 0.1-1 mcg/kg/min infusion by Mixing 1mg of Epi 1:10 into 1L IV bag

96
Q

Lidocaine) Max dose:
Cardiac Arrest from VF/pVT dose:
Refractory VF dose:
Perfusing Arrhythmia dose:
Maintenance Infusion dose:

A

= 3 mg/kg
= 1-1.5 mg/kg IV/IO
= may give additional 0.5-0.75 mg/kg IV/IO in 5-10 mins
= may give additional 0.5-0.75 mg/kg IV/IO in 5-10 mins
= 1-4mg/min (30-50 mcg/kg/min)

97
Q

Mag-Sulfate) Bronchodilation or TdP arrest Adult Dose:
Bronchodilation Pedi Dose:

A

= 1-2G IV/IO over 10-20 mins (Infusion)
= 25-50 mg/kg IV/IO (max 2G) over 15-30 mins (Infusion)

98
Q

NORepi) Adult Dose:
Pediatric Dose:

A

= 0.1–0.5 mcg/kg/min IV/IO infusion
= 0.1–2 mcg/kg/min IV/IO infusion

99
Q

(Labetalol) Max dose:
Adult Dose:

A

= 150mg
= 10 mg IV/O push 1-2 mins & May repeat every 10 mins to max dose

100
Q

Dobutamine) adult dose:
PEDI dose:

A

= 2-20mcg/kg/min- titrate so HR cant rise>10% baseline (pt HR arrival)
= 2-20mcg/kg/min

101
Q

Aspirin)

A

=160-325 mg PO of nonenteric coated ASA.

102
Q

ketamine) Sedation Dose:
Pain dose:

A

= Sedation: 1-2 mg/kg Onset: 30-60 secs, Duration: 10-20 mins
= Pain: 0.2 mg/kg IV/IO (max single dose 20 mg), 0.5 mg/kg IM/IN (if no IV/IO)

103
Q

(Adenosine) indications:

contraindications

A

= 1st for stable narrow complex SVT, Regular & monomorphic wide-complex Tcardia thought from a reentry SVT (SVT w/ BBB)
= Torsades de pointes, Poison/drug-Tcardia, 2nd or 3rd AVB, WPW,DOESNT CONVERT A-FIB/FLUTTER

104
Q

(Amiodarone) Class:
Dynamics:

Indi:

B/c its toxicity indi:
W/ expert consultation may be used for:
Terminal elimination:

A

= Class III antiarrhythmic
= Slows K+ efflux delaying repolarization on all of heart
= VF/Pulseless VT-no/response to shock CPR & Epi, Recurrent hemodynamically unstable VT w/ pulse
= PT w/ life-threatening arrhythmias w/ monitoring
= some atrial & ventricular rhythms w/ life-threatening hypoBP
= Extremely long (half-life lasts max 40 days)

105
Q

(Amiodarone) Contra:
Effects:
Caution b/c:

A

= Allergic, Bradycardias w/ AV blocks, Breastfeeding mothers
= Severe hypotension, Bradycardia, Prolong QT which can lead to TdP
= Toxicity, Causes severe BP drop, Prolong QT which can lead to TdP

106
Q

(Aspirin) Class:
Dynamics:

A

= NSAID & COX inhibiter
= Blocks cyclooxygenase (enzyme that’s basically alarm bell for body)
COX acts upon Arachidonic Acid which in turn gen/s Thromboxane A2, a compound that reg/s the activation of platelets to form a clot

107
Q

(Aspirin) indications:
Contraindications:

A

= Cardiac S/S w/ ischemia etiology
= common allergy, Bronchospasm, Angiodema

108
Q

(Atropine) indications:

Contraindications:
Avoid:

A

= 1st med/ for symptomatic sinus Bcardia, Maybe beneficial AV block, Organophosphate poisoning (large dose r/q) hypothermic Bcardia
= Allergic to drug, Use w/ extreme caution w/ myocardial ischemia
= causes increased myocardial O2 demand so caution w/ Hblock & Doses <0.5mg may result in paradoxical slowing of the heart
May not be effective for infranodal blocks- be prepared to pace

109
Q

(Calcium Chloride) indications:

Contraindications:

A

= Hyper/o/kalemia, Treatment of affects by Ca Chanel blocker OD, HypoBP 2ndary to admin/ of Diltiazem
= cardiac arrest (Unless hyperkalemia suspected)PTs taking Digoxin w/ suspected calcium Chanel blocker OD

110
Q

(Diltiazem/Cardizem)class:
pharmacodynamics:

A

= IV (4) antiarrhythmic Ca channel blocker
= slows auto arrhythmic cells AP in heart atriums by blocking Ca channels

111
Q

(Diltiazem/Cardizem)indi/s:

Contraindications:

A

= 1st med for AFib/Flutter w/ RVR (>150bpm), 2nd med for SVT refractory to Adenosine
= hypoBP, CHF/cardio/shock, Wide-complex Tcardia, WPW, Hypersensitivity

112
Q

(Dobutamine) class:
Dynamics:

A

= synthetic sympathetic agonist
= A&B agonist w/ inotropic prop/s > Chronotropic prop/s

113
Q

(Dopamine) class:
pharmacodynamics

A

= sympathetic agonist
= A/B agonist rate dependent vasopressor +chron/in/Drom/otropic

114
Q

(Dopamine) indications:

Contraindications:

A

= CHF, HypoBP w/ shock signs, 2nd med for sympathetic Bcardia (after Atropine)
= hypovolemic PTs til’ vol/ replaced, pheochromocytoma, Dont mix w/ sodium bicarb

115
Q

(Fentanyl) effects:

dose:

Admin notes:

A

= Resp/ arrest/depres/, AMS, Bcardia & Prolong of QT interval, +vagal tone b/c suppress/ sympathetic path/s, HypoBP, N/V
= 1mcg/kg IV/O(max 100mcg) may repeat PRN in 5-10mins (Max 1mL per nare) if admin/ed IN
= Chest wall rigidity so admin slowly, Depresses every- thing/where

116
Q

(Furosemide) class:
pharmacodynamics:

A

= Loop diuretic
= Blocks absorption of Na, Cl, & water from kidney thus +urinination

117
Q

(Furosemide) indications:

Contraindications:

A

= Acute pulmonary edema in PTs w/ SBP >90-100mmHg (w/o signs of shock) Hypertensive emergencies
= Hypovolemia Hypotension Hypokalemia or other suspected electrolyte abnormalities

118
Q

(Glucagon) class:
pharmacodynamics:

A

= Hormone
= Binds to Glucagon receptors & stim/s adenyl cyclase & +cAMP thus an up-reg/ Ca channels in SA & AV nodal cells

119
Q

(Glucagon) cardiac indications:
Contraindications:

A

= Bradycardia suspected from Beta-Blocker or Ca-Channel Blocker OD
= Bradycardia from etiology (disease origin), Known hypersensitivity

120
Q

(Glucagon) effects
Dose:

A

= Anxiety, Chest palp/s, H/A, N/V, Hyperglycemia
= 3-10mg IV slowly over 3-5 mins Followed w/ infusion 3-5mg per hour

121
Q

(Labetalol) class:
pharmacodynamics:

A

= beta-blocker
= Blocks adrenergic stim/ on B-receptors, causing a slowing of HR

122
Q

(Labetalol) Indications:

Contraindications:
Do not administer to PTs w/ STEMI if following present:

A

= 2nd med/ for SVT after admin/ Adenosine, A-Fib/Flutter w/ RVR Reduce myocardial ischemia in AMI PTs w/ +HRs, Antihypertensive
= Increased risk of cardiogenic shock Hypotension Bradycardia
= signs of heart failure Low cardiac output

123
Q

(Labetalol) Adverse Effects:

Max dose:
Adult Dose:

A

= admin/ after IV Ca-channel blockers can cause severe hypotension, Bcardia, heart blocks & CHF
= 150mg
= 10 mg IV/O push 1-2 mins & May repeat every 10 mins to max dose

124
Q

Lidocaine) Class:
Dynamics:

A

= Ib Antiarrhythmic
= Blocks Na channels in cardiac cells thus depolarization slows & decreases automaticity in ventricles

125
Q

(Lidocaine) Ind:

Contra:

Effects:

A

= Stable monomorphic VT w/ preserved LVF & Alternative to Amiodarone in cardiac arrest by VF/pVT
= Shouldn’t use if PT already received IV Ca channel blockers, Not given prophylactically in AMI setting
= Drowsiness, Slurred Speech, Confusion, Seizures, Hypotension

126
Q

(Mag-Sulfate) Class:
Dynamics:

A

= Misc. Airway med, Mineral, powerful noradrenergic bronchodilator
= Organic Salt act as a physiologic Ca-channel blocker Bronchodilator

127
Q

(Nitroglycerin) class:
pharmacodynamics:

A

= nitrate
= Potent vasodilator opens coronary vessels to improve blood flow to myocardium thus Decreases overall workload of heart/afterload

128
Q

(Nitroglycerin) indications:
Contraindications

A

= Symptoms suggestive of Myocardial ischemia CHF
= HypoBP (SBP<90 or >30 below baseline BP) Severe Bcardia<50bpm, Tcardia>100bpm, Use of phosphodiesterase inhibitors (Boner pills) in last 48 hours, Increased ICP, RVI

129
Q

(Nitroglycerin) effects:

dose:

A

=H/A, Dizziness, Weakness, Tcardia, HypoBP (tablets lose effectiveness after exposed to sun/air)
= 0.4mg SL (pill or spray) → repeat 3x (Q5 mins) for total dose of 1.2mg
DONT SHAKE SPRAY B/C AFFECTS DOSE

130
Q

(NORepi) Class:
dynamics:

A

= Synthetic hormone Vaso-pressor “Sepsis med”
= A/B-adrenergic agonist (A effects > B effects)

131
Q

(NORepi) Indi:
Contra:
Effects:

A

= Normovolemic hypotension, Septic shock, Cardiogenic shock
= hypovolemia PTs til’ Vol/replacement occurred
= Hypertension, Organ ischemia, Cardiac arrhythmia, Tissue necrosis w/ extravasation, Palpitations, Anxiety, N/V

132
Q

(Ondansetron) class:

pharmacodynamics:

A

= selective Seratonin 5-HT3 receptor blocker/antagonist
= Serotonin 5-HT3 receptors @the vagal-N. Can initiate the gag reflex when stim/ed; Zofran is antiemetic/antag/ of 5-HT3 receptors inhibiting serotonin release on central/peripheral vagal nerve

133
Q

(Ondansetron) indi/s:
Contra:

A

= Prevent/control N/B
= Known hypersensitivity to med

134
Q

(Ondansetron)effect:

dose:

A

= HypoBP, Tcardia, Extrapyramidal reaction (=impaired motor control), Prolong QT
= 4-8mg IV (slow), IM, PO

135
Q

(Verapamil) class:
pharmacodynamics:

A

= IV antiarrhythmic Ca channel blocker
= Slows AP of autorhythmic cells in heart by blocking Ca channels

136
Q

(Verapamil) indications:

Contraindications:

A

= 2nd med for A-Fib/Flutter w/ RVR, May use as alterative med (after adenosine), narrow QRS complex Tcardia w/ preserved LV function
= HypoBP (SBP<90), CHF/cardio/ shock, Wide-complex Tcardia, WPW
Hypersensitivity to med

137
Q

Titrate to effect & CONSTANTLY check BP & HR:

A

= NORepi, Epi 1:10, Dopamine, Dobutamine